Xencor Inc Uncategorized Contracts & Agreements

10 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Option Agreement
Xencor Inc
Biotechnology
2025
Description of
Xencor Inc
Biotechnology
2025
Amended and Rest
Xencor Inc
Biotechnology
CA
2024
Amendment to the Cross-License Agreement, dated January 2, 2020, by and between the Company and MedImmune, LLC
Xencor Inc
Biotechnology
2021
CROSS-LICENSE AGREEMENT
Xencor Inc
Biotechnology
DE
2013
Xencor, Inc.111 West Lemon AvenueMonrovia, CA 91016Attn: Bassil Dahiyat, CEOFax: +1 ###-###-#### Copy: Morisson & forester LLP
Xencor Inc
Biotechnology
2013
GPEx-DERIVED CELL LINE SALE AGREEMENT by and between Catalent Pharma Solutions LLC and Xencor, Inc.
Xencor Inc
Biotechnology
NY
2013
Xencor, Inc.111 West Lemon AvenueMonrovia, CA 91016Attn: Bassil Dahiyat, CEOFax: +1 ###-###-#### Copy: Morisson & forester LLP
Xencor Inc
Biotechnology
2013
GPEx-DERIVED CELL LINE SALE AGREEMENT by and between Catalent Pharma Solutions LLC and Xencor, Inc.
Xencor Inc
Biotechnology
NY
2013
INDEMNITY AGREEMENT
Xencor Inc
Biotechnology
DE
2013